Steve M Mccaslin, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 733 Lawrence St, Etowah, TN 37331 Phone: 423-263-4313 Fax: 423-263-4316 |
Dr. Colleen Wynn Mccoy, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 856 Highway 411 N, Etowah, TN 37331 Phone: 423-263-5656 |
Timothy Augustine Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 733 Lawrence St, Etowah, TN 37331 Phone: 423-263-4313 Fax: 423-263-4316 |
Mr. Jeffrey Allan Anderson, DPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 725 Tennessee Ave, Etowah, TN 37331 Phone: 423-263-7824 Fax: 423-263-5714 |
Celeste R Watts, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 841 Highway 411 N, Etowah, TN 37331 Phone: 423-263-5481 Fax: 423-263-5261 |
Laura Lynn Arthur, PHARM.D Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 856 Highway 411 N, Etowah, TN 37331 Phone: 423-263-5656 Fax: 423-263-1803 |
Jessie Lovingood Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 733 Lawrence St, Etowah, TN 37331 Phone: 423-263-4313 |
Gizachew Asefa Seyoum Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 856 Highway 411 N, Etowah, TN 37331 Phone: 423-263-5656 Fax: 423-263-1803 |
Mr. Garry Stephen Shipp, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 856 Highway 411 N, Etowah, TN 37331 Phone: 423-263-5656 Fax: 423-263-1803 |
Dr. Jordan Monroe, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 856 Highway 411 N, Etowah, TN 37331 Phone: 423-263-5656 Fax: 423-263-1803 |
Alfred Kent Beightol Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 856 Highway 411 N, Etowah, TN 37331 Phone: 423-263-5656 Fax: 423-263-1803 |
Jarrett Swafford, PHARM D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 733 Lawrence St, Etowah, TN 37331 Phone: 423-263-4313 |
News Archive
Cancer Research UK scientists have developed a new imaging technique that can show when breast cancer treatment is working, weeks before current methods. The research is published in the British Journal of Cancer today1 (Wednesday).
Findings from a new study on Alzheimer's disease (AD), led by researchers at the University of Saskatchewan, could eventually help clinicians identify people at highest risk for developing the irreversible, progressive brain disorder and pave the way for treatments that slow or prevent its onset.
D. Brent Polk, MD, AGAF, an investigator at Children's Hospital Los Angeles, has been awarded $1.5 million by the National Institute of Diabetes and Digestive and Kidney Diseases of the NIH for the study of tumor necrosis factor (TNF) and its role in inflammatory bowel disease (IBD).
Pfizer Inc. announced today the discontinuation of A4021018 (also known as ADVIGO 1018), a Phase 3 trial examining the effects of investigational compound figitumumab (CP-751,871) in combination with erlotinib as a second/third-line treatment in patients with previously treated advanced non-adenocarcinoma non-small cell lung cancer (NSCLC).
› Verified 4 days ago